Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Erika Kovacs, Ph.D.
Title
Director, Bioassays, Abzena
Bio
Dr. Erika Kovacs is the Director of Bioassays at Abzena where she currently leads the Bioassay team to support drug discovery and development efforts with cell-based assays for lead selection, characterization, potency, and safety. Erika has extensive experience in designing and developing custom assays for unique mode of actions and is the lead in championing technology development efforts to extend Abzena’s portfolio and launch new offerings.
Erika has over 15 years of experience in developing cell-based and biochemical assays to study various aspects of cancer and immune cell function. Most recently, as a postdoctoral candidate at the University of California, Berkeley, Erika studied structure-function relationships in the EGFR-Ras-MAPK cancer signaling pathway and the TCR-Ras-MAPK immune signaling pathway. At Abzena, Erika has been responsible for developing the Fc functional assay package to assess the ADCC and ADCP triggering activity of biologics and delivered a wide range of custom assay development projects. Her expertise lies in designing functional assays for potency assessment and mechanism of action studies.
Erika has an extensive background in studying cancer and immune signaling pathways. Proficient in assay development, optimization and data analysis using a wide range of techniques, such as flow cytometry, fluorescence and luminescence plate-based assays and fluorescence microscopy.
Erika has over 15 years of experience in developing cell-based and biochemical assays to study various aspects of cancer and immune cell function. Most recently, as a postdoctoral candidate at the University of California, Berkeley, Erika studied structure-function relationships in the EGFR-Ras-MAPK cancer signaling pathway and the TCR-Ras-MAPK immune signaling pathway. At Abzena, Erika has been responsible for developing the Fc functional assay package to assess the ADCC and ADCP triggering activity of biologics and delivered a wide range of custom assay development projects. Her expertise lies in designing functional assays for potency assessment and mechanism of action studies.
Erika has an extensive background in studying cancer and immune signaling pathways. Proficient in assay development, optimization and data analysis using a wide range of techniques, such as flow cytometry, fluorescence and luminescence plate-based assays and fluorescence microscopy.
